1. Home
  2. AWH vs KTTA Comparison

AWH vs KTTA Comparison

Compare AWH & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AWH
  • KTTA
  • Stock Information
  • Founded
  • AWH 1993
  • KTTA 2020
  • Country
  • AWH United States
  • KTTA United States
  • Employees
  • AWH N/A
  • KTTA N/A
  • Industry
  • AWH Medical/Dental Instruments
  • KTTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AWH Health Care
  • KTTA Health Care
  • Exchange
  • AWH Nasdaq
  • KTTA Nasdaq
  • Market Cap
  • AWH 1.6M
  • KTTA N/A
  • IPO Year
  • AWH N/A
  • KTTA 2021
  • Fundamental
  • Price
  • AWH $0.11
  • KTTA $1.34
  • Analyst Decision
  • AWH Buy
  • KTTA
  • Analyst Count
  • AWH 2
  • KTTA 0
  • Target Price
  • AWH $4.40
  • KTTA N/A
  • AVG Volume (30 Days)
  • AWH 12.9M
  • KTTA 75.9K
  • Earning Date
  • AWH 03-27-2025
  • KTTA 03-24-2025
  • Dividend Yield
  • AWH N/A
  • KTTA N/A
  • EPS Growth
  • AWH N/A
  • KTTA N/A
  • EPS
  • AWH N/A
  • KTTA N/A
  • Revenue
  • AWH $9,182,000.00
  • KTTA N/A
  • Revenue This Year
  • AWH $11.87
  • KTTA N/A
  • Revenue Next Year
  • AWH $79.10
  • KTTA N/A
  • P/E Ratio
  • AWH N/A
  • KTTA N/A
  • Revenue Growth
  • AWH 0.31
  • KTTA N/A
  • 52 Week Low
  • AWH $0.08
  • KTTA $0.92
  • 52 Week High
  • AWH $3.63
  • KTTA $9.25
  • Technical
  • Relative Strength Index (RSI)
  • AWH 29.83
  • KTTA 51.00
  • Support Level
  • AWH $0.12
  • KTTA $1.12
  • Resistance Level
  • AWH $0.36
  • KTTA $1.39
  • Average True Range (ATR)
  • AWH 0.03
  • KTTA 0.10
  • MACD
  • AWH 0.01
  • KTTA 0.06
  • Stochastic Oscillator
  • AWH 9.00
  • KTTA 88.64

About AWH Aspira Women's Health Inc.

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

Share on Social Networks: